Envestnet Asset Management Inc. Boosts Stake in Stevanato Group S.p.A. $STVN

Envestnet Asset Management Inc. raised its stake in shares of Stevanato Group S.p.A. (NYSE:STVN) by 4.4% during the 2nd quarter, Holdings Channel reports. The fund owned 170,002 shares of the company’s stock after purchasing an additional 7,232 shares during the period. Envestnet Asset Management Inc.’s holdings in Stevanato Group were worth $4,153,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Invesco Ltd. purchased a new stake in shares of Stevanato Group during the 1st quarter worth $19,072,000. Champlain Investment Partners LLC bought a new position in Stevanato Group in the first quarter worth about $15,741,000. MetLife Investment Management LLC purchased a new stake in shares of Stevanato Group during the first quarter valued at about $12,944,000. T. Rowe Price Investment Management Inc. boosted its holdings in shares of Stevanato Group by 13.3% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 3,744,714 shares of the company’s stock valued at $76,468,000 after buying an additional 439,722 shares in the last quarter. Finally, Bar Harbor Wealth Management purchased a new position in shares of Stevanato Group in the 2nd quarter worth approximately $9,081,000.

Stevanato Group Trading Down 4.5%

Shares of Stevanato Group stock opened at €22.62 on Friday. The firm’s 50 day simple moving average is €25.43 and its two-hundred day simple moving average is €24.26. The firm has a market capitalization of $6.85 billion, a price-to-earnings ratio of 39.68, a PEG ratio of 2.32 and a beta of 0.56. Stevanato Group S.p.A. has a 12-month low of €17.49 and a 12-month high of €28.00. The company has a current ratio of 1.89, a quick ratio of 1.30 and a debt-to-equity ratio of 0.26.

Analysts Set New Price Targets

A number of research firms recently commented on STVN. Weiss Ratings reissued a “hold (c)” rating on shares of Stevanato Group in a research report on Wednesday, November 5th. Morgan Stanley increased their price objective on Stevanato Group from $24.00 to $26.00 and gave the company an “equal weight” rating in a report on Tuesday. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, Stevanato Group has a consensus rating of “Moderate Buy”.

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.